MedGene Therapeutics is a biotech company developing ACT treatments for two cancers using NIH patented technology.
MedGene Therapeutics's investors include TIPS Program.
MedGene Therapeutics is headquartered in Silver Spring, United States.
MedGene Therapeutics is a biotech company developing ACT treatments for two cancers using NIH patented technology.
MedGene Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MedGene Therapeutics — Funding & Investors." VCBacked, August 18, 2023, https://www.vcbacked.co/company/medgene-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). MedGene Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/medgene-therapeutics
{{cite web |title=MedGene Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/medgene-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated